Growth Drivers
Clean Science and Technology's growth trajectory is shifting from an investment phase to asset monetization as its HALS segment scales, with HALS revenue doubling from a year earlier and H1 FY27 volumes reaching 67% of the full-year FY26 total. The company reported its highest-ever quarterly revenue in Q2 FY27 on strong demand in its HALS business, rising exports, and improving scale.
Clean Science and Technology targets a 1,000-ton advanced HALS line for commissioning around April or May. Performance Chemical 2 will be commercialized by the third to fourth quarter of FY27.
Risk Factors
Clean Science and Technology's margin came under pressure in Q2 FY27 from high raw material costs connected to crude-linked feedstock prices. The Middle East crisis conflict kept those feedstock prices elevated during the quarter, holding input costs high while raw material costs reached 41%, compared with 35% in Q1 FY27.
Performance Chemical 2 and advanced HALS products require customer validation and time to scale up. Performance Chemical 2 remains in the validation stage, with a realistic first-year utilization target of 20% to 25%.
Product Overview
Clean Science and Technology supplies specialty chemicals through three segments—Performance Chemicals, Pharmaceutical Chemicals, and FMCG Chemicals—whose products enter everyday applications across several industries, supplying an ingredient in daily-use products for the agricultural, cosmetic, aroma, and food industries.
The firm runs four R&D labs that carry out multi-step chemical synthesis and hold approval from the Department of Scientific and Industrial Research, and both of its facilities treat industrial wastewater and recycle it for reuse, operating as zero liquid discharge facilities.
